Hypoxia-augmented constriction of deep femoral artery mediated by inhibition of eNOS in smooth muscle
- Authors
- Han, Jung-A.; Seo, Eun Yeoung; Kim, Hae Jin; Park, Su Jung; Yoo, Hae Young; Kim, Jin Young; Shin, Dong Min; Kim, Jin Kyoung; Zhang, Yin Hua; Kim, Sung Joon
- Issue Date
- Jan-2013
- Publisher
- AMER PHYSIOLOGICAL SOC
- Keywords
- hypoxia/anoxia; arteries; smooth muscle; NADPH oxidase; nitric oxide synthase
- Citation
- AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, v.304, no.1, pp C78 - C88
- Journal Title
- AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Volume
- 304
- Number
- 1
- Start Page
- C78
- End Page
- C88
- URI
- https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/55290
- DOI
- 10.1152/ajpcell.00176.2012
- ISSN
- 0363-6143
1522-1563
- Abstract
- Han JA, Seo EY, Kim HJ, Park SJ, Yoo HY, Kim JY, Shin DM, Kim JK, Zhang YH, Kim SJ. Hypoxia-augmented constriction of deep femoral artery mediated by inhibition of eNOS in smooth muscle. Am J Physiol Cell Physiol 304: C78-C88, 2013. First published October 24, 2012; doi: 10.1152/ajpcell.00176.2012.-In contrast to the conventional belief that systemic arteries dilate under hypoxia, we found that alpha-adrenergic contraction of rat deep femoral artery (DFA) is largely augmented by hypoxia (HVCDFA) while hypoxia (3% Po-2) alone had no effect. HVCDFA was consistently observed in both endothelium-intact and -denuded vessels with partial pretone by phenylephrine (PhE) or by other conditions (e.g., K+ channel blocker). Patch-clamp study showed no change in the membrane conductance of DFA myocytes by hypoxia. The RhoA-kinase inhibitor Y27632 attenuated HVCDFA. The nitric oxide synthase inhibitor [nitro-L-arginine methyl ester (L-NAME)] and soluble guanylate cyclase inhibitor [oxadiazole quinoxalin (ODQ)] strongly augmented the PhE-pretone, while neither of the agents had effect without pretone. NADPH oxidase type 4 (NOX4) inhibitors (diphenylene iodonium and plumbagin) also potentiated PhE-pretone, which was reversed by NO donor. No additive HVCDFA was observed under the pretreatment with L-NAME, ODQ, or plumbagin. Western blot and immunohistochemistry analysis showed that both NOX4 and endothelial nitric oxide synthase (eNOS) are expressed in smooth muscle layer of DFA. Various mitochondria inhibitors (rotenone, myxothiazol, and cyanide) prevented HVCDFA. From the pharmacological data, as a mechanism for HVCDFA, we suggest hypoxic inhibition of eNOS in myocytes. The putative role of NOX4 and mitochondria requires further investigation. The HVCDFA may prevent imbalance between cardiac output and skeletal blood flow under emergent hypoxia combined with increased sympathetic tone.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Red Cross College of Nursing > Department of Nursing > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/55290)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.